Frenlosirsen (sodium)
Frenlosirsen sodium is an antisense oligonucleotide targeted to IRF4. It is used for study of relapsed/refractory multiple myeloma (RRMM) .
Product Specifications
CAS Number
2304711-82-6
Product Name Alternative
ION-935918 (sodium) ; ION251 (sodium)
UNSPSC
12352208
Target
IFNAR
Related Pathways
Immunology/Inflammation
Field of Research
Cancer
Smiles
[Frenlosirsen(sodium)]
Molecular Formula
C177H211N63Na15O89P15S15
Molecular Weight
5935.36
References & Citations
[1]Alexander A. Tong, Silvia Vicenzi, Lara C. Avsharian, Joshua D. Hartman, Trung V. Tran, Ashni A. Vora, Robert A. Vescio, Barry A. Paul, Caitlin L. Costello, T. Jesse Kwoh, Leslie A. Crews; Abstract CT146: Safety, tolerability and molecular correlates of the IRF4-targeted antisense oligonucleotide frenlosirsen in patients with relapsed/refractory multiple myeloma: A phase 1a dose escalation trial. Cancer Res 15 April 2025; 85 (8_Supplement_2) : CT146.
Shipping Conditions
Room temperature
Scientific Category
Oligonucleotides
Clinical Information
Phase 1
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC740226-500 1x 500 µL
Pmel17 / gp100 / SILV (NKI-beteb), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC040391-500 1x 500 µL
CD81 / TAPA-1 (1.3.3.22), CF405S conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC472452-100 1x 100 µL
HER-2 / c-erbB-2 / neu / CD340 (ERBB2/2452), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC680525-500 1x 500 µL
CD63 (MX-49.129.5), CF568 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 